BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26670173)

  • 1. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
    Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G
    Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.
    Gorzelak-Pabiś P; Zyzak S; Krewko Ł; Broncel M
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):494-501. PubMed ID: 27511466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
    Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
    Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
    Proietti M; Lane DA; Lip GY
    Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
    Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
    Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the SAMe-TT
    Zulkifly H; Lip GYH; Lane DA
    Heart Rhythm; 2018 Apr; 15(4):615-623. PubMed ID: 29180122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
    Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
    PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of SAMe-TT
    Wang K; Lu Y; Simegn MA; Xue H; Asinger RW
    J Thromb Thrombolysis; 2023 Jan; 55(1):175-180. PubMed ID: 36352057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
    Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J
    Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant selection in relation to the SAMe-TT
    Ntaios G; Huisman MV; Diener HC; Halperin JL; Teutsch C; Marler S; Gurusamy VK; Thompson M; Lip GYH; Olshansky B;
    Hellenic J Cardiol; 2021; 62(2):152-157. PubMed ID: 33338644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.
    Esteve-Pastor MA; Roldán V; Valdés M; Lip GY; Marín F
    Expert Rev Cardiovasc Ther; 2016; 14(2):177-87. PubMed ID: 26559964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Lip GY; Waldo AL; Ip J; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen M; Halperin JL;
    Am J Cardiol; 2016 Dec; 118(11):1680-1684. PubMed ID: 27665206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation.
    Bryk AH; Plens K; Undas A
    Cardiol J; 2017; 24(5):477-483. PubMed ID: 28353307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Marin F; Gálvez J; Valdés M; Vicente V; Lip GYH
    Am J Med; 2014 Nov; 127(11):1083-1088. PubMed ID: 24858062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study.
    Szymanski FM; Filipiak KJ; Platek AE; Hrynkiewicz-Szymanska A; Kotkowski M; Kozluk E; Kiliszek M; Sierdzinski J; Opolski G
    Sleep Breath; 2015 Sep; 19(3):849-56. PubMed ID: 25566942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.
    Matiello M; Nadal M; Tamborero D; Berruezo A; Montserrat J; Embid C; Rios J; Villacastín J; Brugada J; Mont L
    Europace; 2010 Aug; 12(8):1084-9. PubMed ID: 20488856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Xu H; Wang J; Yuan J; Hu F; Yang W; Guo C; Luo X; Liu R; Cui J; Gao X; Chun Y; Qiao S
    J Am Heart Assoc; 2020 Apr; 9(8):e015013. PubMed ID: 32297565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.